- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
UCB (UCB)
Index:
- Change Today: 0.00
- 52 Week High: 260.20
- 52 Week Low: 129.35
- Currency: Euro
- Shares Issued: 190.00m
- Volume: 0
- Market Cap: 46,018m
- Beta: 1.91
UCB Overview
UCB is a Belgian manufacturer of biopharmaceutical products. The company is engaged in the provision of therapy for central nervous system disorders, inflammatory and oncology disorders. UCB head office is located in Brussels.
Financials
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.6% | |
| Div Cover | 4.0 | |
| Op Mrgn | 23.6% | |
| ROCE | 33.1% |
| Latest | F'cast | |
|---|---|---|
| P/E | 43.2 | |
| PEG | 0.2 | |
| Pr/Revenue | 8.2 | |
| Pr/Book | 4.6 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 15.3% | |
| PBT | 163.7% | |
| EPS | 209.9% | |
| DPS | 2.2% |
UCB Fundamentals
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
| 31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
| 31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
| 31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
| 31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
UCB Forecasts
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 7,151.06 | 1,564.29 | 765.57¢ | 31.6 | 0.9 | +36% | 142.08¢ | 0.0% |
| 31-Dec-26 | 8,186.18 | 2,160.43 | 1,009.34¢ | 24.0 | 0.8 | +32% | 146.27¢ | 0.0% |
| 31-Dec-27 | 9,356.73 | 2,936.70 | 1,314.52¢ | 18.4 | 0.6 | +30% | 149.70¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
UCB ShareCast News
| Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
UCB Top Newspaper Links
| GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
| UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
| Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
UCB Market Data
| Currency | Euro |
| Share Price | 242.20 |
| Change Today | 0.00 |
| % Change | 0.00 % |
| 52 Week High | 260.20 |
| 52 Week Low | 129.35 |
| Volume | 0 |
| Shares Issued | 190.00m |
| Market Cap | 46,018m |
| Beta | 1.91 |
What The Brokers Say
| Strong Buy | 6 |
| Buy | 11 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 21 |
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN